Roger Adsett

Roger Adsett

DirectoratINSMED· In proxies 2021–2025

Pay in FY2025+10% from the year before · INSMED stock +152.1% the same year

Roger Adsett was paid $4.7M in FY2025 (Dec), up 10%. INSMED stock rose 152.1% that year.

Pay$100 in the stock at the end of FY20 → $523
Pay is from the Summary Compensation Table of each INSMED proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Definium TherapeuticsPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  2. INSMEDPublic company · 5 yr
    • Chief Operating Officer2021 – Present · 5 yrStock in role +174%
  3. Landos Biopharma, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • Definium TherapeuticsDirector · -1 yr on the boardIndependent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?